Jean-François Morin
Direktor/Vorstandsmitglied bei Orphalan SA
Ursprung des Netzwerks ersten Grades von Jean-François Morin
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
BPIFrance Investissement SAS
 BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development.
76
| Subsidiary | Investment Managers | 76 |
Ona Therapeutics SL
 Ona Therapeutics SL Pharmaceuticals: MajorHealth Technology Ona Therapeutics SL is a biotech company based in Barcelona, Spain that specializes in discovering and developing therapeutic biologics targeting tumor metastatic-initiating cells and lipid metabolism. The Spanish company's focus is on developing novel therapies against advanced cancer. The company was founded in 2019 by Salvador Aznar Benitah and Valerie Liesbeth Brigitte Vanhooren, with Valerie Liesbeth Brigitte Vanhooren serving as CEO since incorporation.
9
| Holding Company | Pharmaceuticals: Major | 9 |
Orphalan SA
 Orphalan SA Pharmaceuticals: MajorHealth Technology GMP-Orphan SA engages in the research and development in biotechnology. It focuses on developing and designing drugs for life-threatening and rare diseases. The company was founded by Frederic Marin on July 18, 2011 and is headquartered in Paris, France.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Jean-François Morin
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
Bpifrance Participations SA /PRIVATE EQUITY/
 Bpifrance Participations SA /PRIVATE EQUITY/ Investment ManagersFinance Bpifrance Participations SA/ PRIVATE EQUITY/ (BPIfrance Participations PE) is the private equity division of Bpifrance Participations SA subsidiary of State-owned Caisse des Dépots & Consignations headquartered in France. Formerly known as Fonds Stratégique d'Investissement SA (Private Equity), the firm was established in 2008 by the Government of France in an aim to strengthen distressed companies of strategic importance for the French economy. Based in Paris, BPIfrance Participations specializes in fund of funds and direct investments in French intermediate-sized companies. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor Private Equity Analyst Private Equity Analyst | |
| TXCELL | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Sciences Po | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| Ecole Polytechnique | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
CDC Croissance SA
 CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Chairman Chief Investment Officer Corporate Officer/Principal Chief Executive Officer | |
| VERGNET S.A. | Electrical Products | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| EUTELSAT COMMUNICATIONS | Major Telecommunications | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| POXEL | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| Ecole Nationale d'Administration | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Advent Venture Partners LLP
 Advent Venture Partners LLP Investment ManagersFinance Advent Venture Partners LLP (AVP) is a private equity/venture capital firm founded in 1981 by David James Scott Cooksey. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Investor | |
| SUPERSONIC IMAGINE | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| Université Paris Dauphine-PSL | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| ADVICENNE | Pharmaceuticals: Generic | Chairman Director/Board Member Director/Board Member | |
| SENSORION | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| GENSIGHT BIOLOGICS S.A. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| MERSEN | Electrical Products | Director/Board Member Director/Board Member Director/Board Member | |
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| EM Lyon Business School | College/University | Graduate Degree Undergraduate Degree Graduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
ENYO Pharma SA
 ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Bpifrance Participations SA | Financial Conglomerates | Chief Executive Officer Chief Investment Officer Director/Board Member | |
| PIXIUM VISION | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
| ORANGE | Wireless Telecommunications | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| Université Paris II Panthéon Assas | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| SEB S.A. | Electronics/Appliances | Director/Board Member Director/Board Member | |
| Ecole Nationale des Ponts et Chaussées | College/University | Graduate Degree Undergraduate Degree | |
Banque Publique d'Investissement
 Banque Publique d'Investissement Finance/Rental/LeasingFinance Banque Publique Dinvestissement (Bpifrance) is the French Government's public investment institution which was created in 2013 to 'serve the future' by providing financing solutions tailored to each stage of a company's life. Located in Maisons-Alfort, Bpifrance aims to invest EUR 12 billion in French companies by 2017. Their three main tasks are: to help overcome market failures that hamper the financing of enterprises, especially SMEs; to invest in the development of strategic sectors such as digital conversion, environmental and energy, and the social and solidarity economy; and to act as a lever to develop territories in connection with regions in France. Bpifrance includes OSEO, CDC Entreprises, FSI and FSI Regions. OSEO is a public institution whose mission is to support innovation and growth of SMEs. CDC Entreprises is a management company that invests directly or indirectly in SMEs and ETIs at all stages of their development. FSI is an investment fund established by the French government in 2008 to help French companies seeking stable investors to finance their development projects and FSI Régions is a management company which provides regional investment capital. In 2013, OSEO will become Bpifrance Financement and Bpifrance Investissement will regroup CDC Entreprises, FSI and FSI régions. CDC Entreprises, FSI and FSI Régions will merge to become Bpifrance Investment. | Finance/Rental/Leasing | Chief Executive Officer Corporate Officer/Principal | |
| EUROAPI | Biotechnology | Director/Board Member Director/Board Member | |
| FERMENTALG | Food: Specialty/Candy | Director/Board Member Director/Board Member | |
| BIOM'UP | Medical Specialties | Director/Board Member Director/Board Member | |
| BALYO | Industrial Machinery | Director/Board Member Director/Board Member | |
| VOLUNTIS S.A. | Packaged Software | Director/Board Member Director/Board Member | |
FT1CI
 FT1CI Other Metals/MineralsNon-Energy Minerals FT1CI provides services to nuclear power plants such as uranium mining and fuel production, maintenance and engineering services, recycling and processing of nuclear waste, and manufactures nuclear power generation, transmission and distribution equipment. It is headquartered in Paris, France. | Other Metals/Minerals | Chief Executive Officer Director/Board Member | |
Axonics Women's Health Ltd.
 Axonics Women's Health Ltd. Pharmaceuticals: MajorHealth Technology Contura Ltd. specializes in the distribution and sale of healthcare products, both in pharmaceuticals and medical devices. The firm focuses in the fields of urology and urogynaecology. Its products include bulkamid, cystistat, and aquamid. The company was founded by Henry Geoffrey McMillan in 2000 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
iTeos Therapeutics SA
 iTeos Therapeutics SA Pharmaceuticals: MajorHealth Technology iTeos Therapeutics SA engages in the discovery of immunomodulators for cancer therapy. It operates as a biotechnology company which focuses on targeting metabolism of the tumor microenvironment through development of small-molecule immunomodulators for cancer treatment. The firm develops small molecules designed to target the tumor microenvironment by inhibiting cancer-induced immune suppression. Targeting such resistance mechanisms will enhance the clinical efficacy of both standards of care treatments as well as the newer immunomodulatory therapies based on the blockade of immune checkpoints. The company was founded in 2011 by Michel Detheux and Benoit Van den Eynde and is headquartered in Gosselies, Belgium. | Pharmaceuticals: Major | Director/Board Member Founder | |
Josso SAS
 Josso SAS Forest ProductsNon-Energy Minerals Josso SA manufactures of wooden products. It engages in lumbering, sawmill, pallets, and timber. The company was founded in 1910 and is headquartered in Le Roc Saint André, France. | Forest Products | Director/Board Member Director/Board Member | |
Bpifrance SA
 Bpifrance SA Finance/Rental/LeasingFinance Bpifrance SA provides aids and financial support to small and medium companies. Its solutions include loans, insurance, warranties, and equity investments. The creation of the BPI was formalized by Law no. 2012-1559 on 31 December 2012, amending Ordinance no. 2005-722 of June 29, 2005, relating to the creation of the public institution OSEO, which became EPIC BPI-Groupe then EPIC Bpifrance, and the public limited company OSEO (now Bpifrance). The company was founded in 1923 and headquartered in Maisons-Alfort, France. | Finance/Rental/Leasing | Chief Executive Officer Director/Board Member | |
| EO2 | Industrial Specialties | Director/Board Member Director/Board Member | |
Amundi Private Equity Funds SA
 Amundi Private Equity Funds SA Investment ManagersFinance Amundi Private Equity Funds SA (Amundi PEF) is the private equity subsidiary of Amundi SA, itself a subsidiary of Crédit Agricole SA (XP: ACA) in France. Formerly known as CAAM-CI, founded in 1999 as CPR Private Equity, Amundi PEF was formed in 2009 by combining the Crédit Agricole and Société Générale asset management operations. The firm is headquartered in Paris and has additional offices in Bucharest, Cairo, Casablanca, Tunis and Warsaw. They invest in companies at all stages of development, providing institutional and individual investors with a wide spectrum of investment opportunities. | Investment Managers | Private Equity Investor Private Equity Analyst | |
Caisse des Dépôts & Consignations
 Caisse des Dépôts & Consignations General GovernmentGovernment Caisse des Dépôts & Consignations engages in missions of public interest and operates on behalf of central, regional, and local governments in France. The firm serves as an investment manager for the government and oversees tax-exempt funds collected by savings banks. The company was founded in 1816 and is headquartered in Paris, France. | General Government | Corporate Officer/Principal Corporate Officer/Principal | |
| INTEGRAGEN | Medical/Nursing Services | Director/Board Member Director/Board Member | |
UroMems SAS
 UroMems SAS Medical SpecialtiesHealth Technology UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France. | Medical Specialties | Director/Board Member Director/Board Member | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Aledia SAS
 Aledia SAS Electrical ProductsProducer Manufacturing Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France. | Electrical Products | Director/Board Member Director/Board Member | |
Oddo BHF SCA (Broker)
 Oddo BHF SCA (Broker) Investment Banks/BrokersFinance Oddo BHF SCA (Broker) is the securities brokerage division of Oddo BHF SCA, a financial services company headquartered in Paris, France. The firm provides equity brokerage services to various investors. | Investment Banks/Brokers | Analyst-Equity Analyst-Equity | |
Jolt Capital SAS
 Jolt Capital SAS Investment ManagersFinance Jolt Capital SAS (Jolt Capital) is an independent private equity firm founded in 2011 by Jean Schmitt. The firm is headquartered in Paris, France. | Investment Managers | Private Equity Investor Consultant / Advisor |
Statistik
International
| Frankreich | 47 |
| Vereinigtes Königreich | 3 |
| Belgien | 2 |
| Vereinigte Staaten | 2 |
Sektoral
| Health Technology | 16 |
| Finance | 13 |
| Consumer Services | 9 |
| Producer Manufacturing | 5 |
| Communications | 3 |
Operativ
| Director/Board Member | 505 |
| Private Equity Investor | 102 |
| Corporate Officer/Principal | 48 |
| Chairman | 47 |
| Independent Dir/Board Member | 43 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Anne-Sophie Herelle | 65 |
| Nicolas Dufourcq | 53 |
| Vanessa Giraud | 42 |
| Chahra Khaoua Epouse Louafi | 26 |
| Florence Parly | 25 |
| Mohammed Malik | 24 |
| Philippe Boucheron | 24 |
| Olivier Mareuse | 23 |
| Maïlys Ferrère | 21 |
| Laurent Arthaud | 21 |
| José Antonio Mesa Cejudo | 20 |
| Olivier Martinez | 19 |
| Marie-Laure Garrigues | 19 |
| Pamela Klein | 19 |
| Philippe Braidy | 18 |
- Börse
- Insiders
- Jean-François Morin
- Unternehmensverbindungen
